PDCD1 and neoplasm: Furthermore, PD-L1 expression has been shown to increase when tumor cells are exposed to interferon (IFN)-γ during therapy, indicating that PD-L1 blockade might have an advantage over the PD-1-blocking antibody in some cases27,28.